US 12,440,677 B2
Multiple-lead implantable systems for stimulation of cranial nerves
Lynn Elliott, Maple Grove, MN (US); and Stephen C. Masson, Jr., Raleigh, NC (US)
Assigned to NUXCEL2, L.L.C., Reno, NV (US)
Filed by NuXcel2, L.L.C., Brooklyn Park, MN (US)
Filed on Jul. 6, 2022, as Appl. No. 17/858,668.
Application 17/858,668 is a continuation of application No. PCT/US2021/012723, filed on Jan. 8, 2021.
Claims priority of provisional application 62/959,617, filed on Jan. 10, 2020.
Prior Publication US 2022/0339441 A1, Oct. 27, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61B 5/08 (2006.01); A61N 1/05 (2006.01); A61N 1/372 (2006.01); A61N 1/375 (2006.01); A61B 5/00 (2006.01); A61B 5/11 (2006.01)
CPC A61N 1/3611 (2013.01) [A61B 5/08 (2013.01); A61N 1/0551 (2013.01); A61N 1/0556 (2013.01); A61N 1/36125 (2013.01); A61N 1/37518 (2017.08); A61B 5/11 (2013.01); A61B 5/4836 (2013.01); A61N 1/36078 (2013.01); A61N 1/375 (2013.01)] 17 Claims
OG exemplary drawing
 
1. An implantable system for neuromodulation of cranial nerves, the system comprising:
a first housing configured for implantation in an anterior cervical region of a patient, adjacent to or under a mandible of the patient and between a mylohyoid muscle and a digastric muscle that bound respective portions of the anterior cervical region of the patient, wherein the first housing includes a first housing wall configured for implantation adjacent to the mylohyoid muscle and the first housing includes at least one other housing wall that is tapered and extends away from the first housing wall toward the digastric muscle;
a battery provided in the first housing;
a first electrode lead coupled to the first housing, the first electrode lead comprising at least one electrode configured to be disposed at or near a first cranial nerve target in the patient;
a second electrode lead coupled to the first housing, the second electrode lead comprising at least one electrode configured to be disposed at or near a second cranial nerve target in the patient, wherein the first and second cranial nerve targets are on opposite sides of a sagittal midline of the patient; and
a signal generator circuit provided in the first housing and configured to use power from the battery to generate electrical neuromodulation signals for delivery to the cranial nerve target using the at least one electrode of the first electrode lead or the second electrode lead, wherein the neuromodulation signals are configured to treat a breathing disorder or a sleep disorder of the patient.